Big buy

Reshma Kewalramani: large open-market buy of VRTX

$2.2M open-market purchase by Reshma Kewalramani, CEO & President at Vertex Pharmaceuticals Inc, filed August 7, 2025. Learn more

Feed status Last SEC check:Loading Last Filing: Loading
View VRTX
Access Free feed
Quick read What does this view show?

What this is

Single filing record

This page shows the rows from one Form 4 filing as reported to the SEC.

Why it matters

Read the SEC filing

The original SEC document is the source record. Always verify before drawing conclusions.

How to read it

Role, size, timing

Insider activity carries more weight from senior officers, large dollar values, and clustered timing.

Big BuyVRTX
$547.65+0.57% today

Reshma Kewalramani · CEO & President at Vertex Pharmaceuticals Inc

$2.2M

Reshma Kewalramani bought $2.2M of VRTX (Vertex Pharmaceuticals Inc).

Filed August 7, 2025

Filings

Recent insider trades

Status Loading

Loading public insider data...

Latest visible filing loading.

Public Form 4 filings, normalized for cleaner scanning. What do these codes mean?

TickerType & RoleValue

View all VRTX insider activity →

Share

Share this story

Reshma Kewalramani bought $2.2M of VRTX. Large open-market insider purchase reported on SEC Form 4.

Weekly recap

Get the easier version in your inbox.

Start with the free weekly recap. Upgrade later if you want the paid daily brief.

Free weekly recap. No login required. Unsubscribe any time.

Method Public Form 4 filings, normalized for cleaner scanning. Filtered rows stay available in All Form 4 Filings and ticker history. Which view should I use? →